Unicycive Therapeutics Inc (UNCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,729 | -30,544 | -18,058 | -10,017 | -2,264 |
| Depreciation Amortization | 428 | 284 | 161 | 501 | 186 |
| Other Working Capital | -427 | -93 | 1,178 | -105 | -166 |
| Other Operating Activity | 8,153 | 12,070 | 1,068 | 3,854 | 785 |
| Operating Cash Flow | $-28,575 | $-18,283 | $-15,651 | $-5,767 | $-1,459 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -72 | -12 | -2 | -29 | N/A |
| Investing Cash Flow | $-72 | $-12 | $-2 | $-29 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,346 | 1,580 |
| Debt Repayment | -527 | -496 | -482 | -1,361 | -160 |
| Common Stock Issued | N/A | N/A | 11 | 22,390 | 141 |
| Dividend Paid | -1,095 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 46,710 | 28,037 | 0 | 0 | -117 |
| Financing Cash Flow | $45,088 | $27,541 | $-471 | $22,375 | $1,444 |
| Beginning Cash Position | 9,701 | 455 | 16,579 | N/A | 15 |
| End Cash Position | 26,142 | 9,701 | 455 | 16,579 | N/A |
| Net Cash Flow | $16,441 | $9,246 | $-16,124 | $16,579 | $-15 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,575 | -18,283 | -15,651 | -5,767 | -1,459 |
| Capital Expenditure | -72 | -12 | -2 | -29 | N/A |
| Free Cash Flow | -28,647 | -18,295 | -15,653 | -5,796 | -1,459 |